/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

Daniel Ek's Neko Health, which offers AI-based full-body scans, raised $700M co-led by Lightspeed and O.G. Venture Partners, sources say at a ~$7B valuation

New York Times Bernhard Warner

Context & Ripple Effects

Neko Health moved from stealth development of an AI-powered full-body scanner to a London launch, its first expansion beyond Sweden. Its prior reported financing was a $260M Series B led by Lightspeed at a $1.7B valuation.

The reported new round keeps Lightspeed involved while adding O.G. Venture Partners as co-lead, indicating that Neko’s expansion story is now being financed at a much larger scale than in the prior coverage.

First-order effects

  • Neko Health reportedly gains $700M of new capital and a roughly $7B valuation, materially strengthening its financing position relative to its earlier Series B.
  • Lightspeed deepens its exposure to Neko Health, while O.G. Venture Partners becomes a prominent backer of the company’s AI-based scanning model.

Second-order effects

  • The valuation step-up creates a sharper benchmark for other AI-enabled health-screening companies seeking growth capital, particularly those moving from a single-market operation toward international rollout.
  • Neko’s better-funded position may raise the competitive bar for providers building or operating AI-assisted screening services in markets it enters, including London.

Third-order effects

  • If similarly large financings continue, AI-based preventive screening could develop as a distinct, capital-intensive health-tech category in which scale, clinical deployment, and geographic footprint matter alongside the underlying AI.
  • The pattern also suggests investor appetite is shifting from funding AI health tools in development toward backing companies attempting to turn them into repeatable service networks; whether that produces durable leadership remains unproven in the supplied coverage.

The trend: This is one data point in the commercialization of AI-enabled healthcare services, as companies move from product development and initial city launches toward heavily financed expansion platforms.

Discussion

  • @nbtjacklyn Jacklyn Dallas on x
    This is big news Very excited about it The way medicine works right now feels incredibly outdated The future of medicine is preventative not reactive!
  • @hypervisible.blacksky.app @hypervisible.blacksky.app on bluesky
    “New investors in the latest round include musician will.i. am, tennis player Maria Sharapova, Meta chief Mark Zuckerberg and his wife, Priscilla Chan, and former footballer Thierry Henry.”
  • Renée Gutierrez Renée Gutierrez on linkedin
    The most important number in this story is not $700 million.  —  It is 350,000.  —  That is how many people Neko Health says have registered or joined the waitlist for its preventive health scans. …